CN105802995A - Gene expression system for producing recombinant protein by using CHO cells and eukaryotic expression vector - Google Patents
Gene expression system for producing recombinant protein by using CHO cells and eukaryotic expression vector Download PDFInfo
- Publication number
- CN105802995A CN105802995A CN201410853298.0A CN201410853298A CN105802995A CN 105802995 A CN105802995 A CN 105802995A CN 201410853298 A CN201410853298 A CN 201410853298A CN 105802995 A CN105802995 A CN 105802995A
- Authority
- CN
- China
- Prior art keywords
- expression
- phlx201
- gene
- carrier
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000014509 gene expression Effects 0.000 title claims abstract description 121
- 239000013604 expression vector Substances 0.000 title claims abstract description 42
- 210000004978 chinese hamster ovary cell Anatomy 0.000 title claims abstract description 10
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title claims abstract description 6
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 40
- 210000004027 cell Anatomy 0.000 claims abstract description 34
- 238000012216 screening Methods 0.000 claims abstract description 24
- 108020002326 glutamine synthetase Proteins 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 239000013612 plasmid Substances 0.000 claims description 32
- 108091008146 restriction endonucleases Proteins 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 239000012634 fragment Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 claims description 17
- 241000699802 Cricetulus griseus Species 0.000 claims description 17
- 210000001672 ovary Anatomy 0.000 claims description 17
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 101150074355 GS gene Proteins 0.000 claims description 15
- 230000009471 action Effects 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 8
- 230000009466 transformation Effects 0.000 claims description 6
- 239000013598 vector Substances 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 238000005457 optimization Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 2
- 238000003209 gene knockout Methods 0.000 claims description 2
- 230000010354 integration Effects 0.000 abstract description 5
- 230000010474 transient expression Effects 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 23
- 238000001962 electrophoresis Methods 0.000 description 17
- 239000000047 product Substances 0.000 description 15
- 230000004927 fusion Effects 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 12
- 230000007850 degeneration Effects 0.000 description 10
- 230000029087 digestion Effects 0.000 description 10
- 230000003321 amplification Effects 0.000 description 9
- 230000005611 electricity Effects 0.000 description 9
- 238000003199 nucleic acid amplification method Methods 0.000 description 9
- 230000004087 circulation Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 239000011148 porous material Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 4
- 108090000364 Ligases Proteins 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 210000004962 mammalian cell Anatomy 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000010079 rubber tapping Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 108010077544 Chromatin Proteins 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010022394 Threonine synthase Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 230000009668 clonal growth Effects 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 102000004419 dihydrofolate reductase Human genes 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 102000005396 glutamine synthetase Human genes 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000000703 high-speed centrifugation Methods 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 108010089921 CTCGAG-specific type II deoxyribonucleases Proteins 0.000 description 1
- 101150074155 DHFR gene Proteins 0.000 description 1
- 102100024746 Dihydrofolate reductase Human genes 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010042546 GCGGCCGC-specific type II deoxyribonucleases Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 108020001096 dihydrofolate reductase Proteins 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to the field of biotechnology, and in particular, relates to a gene expression system for producing a recombinant protein by using CHO cells and a eukaryotic expression vector. The invention provides the pHLX201 eukaryotic expression vector including a GS expression unit, the GS expression unit has the sequence comprising an SV40L promoter gene sequence and a glutamine synthetase gene sequence which are arrayed successively in a direction from 5' to 3', wherein the SV40L promoter gene sequence is shown in SEQ ID NO:2, and the glutamine synthetase gene sequence is shown in SEQ ID NO:3. The expression system provided by the invention can realize integration and efficient expression of exogenous genes in a CHO cell genome. The preparation method of the system mainly includes that the eukaryotic expression vector is constructed, is suitable for transient expression of a target gene in the CHO cells and is suitable for screening target gene high-expression cell lines. The CHO expression system can be used for realizing integration and expression of the recombinant protein, a monoclonal antibody and the like in the CHO cells, and has wide application prospects.
Description
Technical field
The present invention relates to biological technical field, particularly relate to a kind of gene expression system utilizing Chinese hamster ovary celI to produce recombiant protein and carrier for expression of eukaryon.
Background technology
Gene expression system used by genetic engineering field is roughly divided into protokaryon, yeast, plant, insecticide and mammalian cell expression system.Compared with other system, the advantage of mammalian cell expression system is in that to instruct the correct folding of protein, there is provided complicated glycosylation modified, thus expression product in molecular structure, physicochemical property and biological function closest to natural higher organism protein molecule.The large-scale production technology of mammalian cell is also day by day ripe and perfect.Therefore, prepare therapeutic recombinant proteins medicine by mammaliancellculture expression and have become as the mainstream technology of current field of biological pharmacy.Listed at present and carried out in the pharmaceutical grade protein of clinical trial, having mostly come from mammalian cell, and this wherein Chinese hamster ovary cell (Chinese hamster ovary celI) be the most frequently used genetically engineered host cell.
In order to obtain efficient exogenous gene expression, genetic engineering Chinese hamster ovary celI often uses dihydrofolate reductase (Dihydrofolatereductase, DHFR) and glutamine synthetase (Glutaminesynthetase, GS) carry out gene amplification and screening.Glutamine synthase expression system (GS expression system) often only needs one to take turns pressurization screening, and required screening time is short;Need not adding glutamine in amplification culture process additionally, due to the cell strain carrying GS gene, therefore, the impact by metabolic by-product NH3 poison is less, is conducive to process optimization and amplification culture.
The expression vector utilizing GS, DHFR gene amplification and screening system is many by developed country's exploitations such as the U.S.; its patent protection, technology transfer barrier significantly limit China's medicine biological technique and industrial expansion; therefore a kind of expression system with independent intellectual property right now it is badly in need of, the progress of exploitation and China's biological-pharmacy to promote associated protein medicine.
Summary of the invention
The shortcoming of prior art in view of the above, it is an object of the invention to provide a kind of pHLX201 carrier for expression of eukaryon, is used for solving the problems of the prior art.
For achieving the above object and other relevant purposes, first aspect present invention provides a kind of pHLX201 carrier for expression of eukaryon, unit is expressed including GS, described GS expresses the sequence of unit and includes SV40L promoter gene sequence (SV40Lpromoter), the glutamine synthetase gene sequence (GS) that 5 ' to 3 ' directions are arranged in order, and described SV40L promoter gene sequence is such as shown in SEQIDNO:2;Described glutamine synthetase gene sequence is such as shown in SEQIDNO:3.
Preferably, described GS expresses unit gene order such as shown in SEQIDNO:4.
Preferably, described GS expresses the sequence of unit and also includes restriction enzyme site sequence, and described GS expresses the sequence of unit and includes restriction enzyme site sequence, SV40L promoter gene sequence (SV40Lpromoter), glutamine synthetase gene sequence (GS) and the restriction enzyme site sequence that 5 ' to 3 ' directions are arranged in order.
More excellent, one or more the combination in HindIII enzyme, NotI enzyme, XhoI enzyme of the described restriction enzyme site sequence.
It is further preferred that the described GS expression unit sequence containing restriction enzyme site can as shown in SEQIDNO:5.
Preferably, pHLX201 carrier for expression of eukaryon provided by the present invention is to be obtained by the transformation of pHLX101 carrier for expression of eukaryon.
More excellent, described pHLX201 carrier for expression of eukaryon is second exogenous gene expression unit of insertion between SV40PolyA end and the promotorA of the GS gene order of pHLX101 carrier, i.e. promoter A, exogenous gene and SV40PolyA, more original GS expression unit is replaced with new GS gene order and promoter thereof.
The preparation method that second aspect present invention provides described pHLX201 carrier for expression of eukaryon, is obtained by the transformation of pHLX101 carrier for expression of eukaryon, and transformation process mainly comprises the steps:
By the method for PCR by pHLX101 vector linearization, and add restriction enzyme site sequence at two ends, change single-gene expression vector into double gene expression vector;Replace original GS and express unit, adopt PCR, enzyme action, connection method new GS expressed unit insert expression vector, screen, identify and correct connect the pHLX201 carrier for expression of eukaryon that product is the present invention.
Method particularly includes:
1) preparation of dual-gene carrier: utilize primer S322 (SEQIDNO:6) and S323 (SEQIDNO:7) to expand light chain of antibody and express unit, linearizing antibody heavy chain gene expression vector is obtained as the skeleton building dual-gene carrier again with primer S324 (SEQIDNO:8), S325 (SEQIDNO:9), two above fragment is connected, converts, screen correct transformant;
2) GS expresses the optimization of unit: with SV40L promoter composition, the glutamine synthetase gene of Chinese hamster ovary celI is expressed unit, and add restriction enzyme site at two ends simultaneously, connect insertion pHLX101 double gene expression vector respectively by enzyme action, replace original GS on carrier and express unit.
Preferably, described pHLX201 carrier for expression of eukaryon is applicable to Chinese hamster ovary celI.
More excellent, described pHLX201 carrier for expression of eukaryon is applicable to CHO-S cell.
Third aspect present invention discloses a kind of pHLX201-CHO eukaryotic expression system, including pHLX201 carrier for expression of eukaryon of the present invention and Chinese hamster ovary cell.
Preferably, described Chinese hamster ovary cell is the CHO-S cell of GS gene knockout.
Fourth aspect present invention discloses the method utilizing described pHLX201-CHO eukaryotic expression system to prepare recombiant protein, comprises the steps:
1) structure of recombiant plasmid: first the exogenous gene of recombiant protein 1 or recombiant protein 2 is inserted respectively in pHLX201 single-gene expression vector, the recombiant plasmid that then construction expression is dual-gene again;
2) screening of expression system: recombinant plasmid transformed Chinese hamster ovary celI, the cell strain of screening stably express is as pHLX201-CHO eukaryotic expression system;
3) the pHLX201-CHO eukaryotic expression system adopting previous step screening expresses recombiant protein.
Described step 1) in after external source gene insertion vector, constituting exogenous gene expression unit, the sequence of described exogenous gene expression unit includes promoter sequence, exogenous gene sequence and termination signal and the polyA tailing signal sequence that 5 ' to 3 ' directions are arranged in order.
More excellent, step 1) sequence of described exogenous gene expression unit also includes the restriction enzyme site sequence at two ends.
More excellent, step 1) particularly as follows: exogenous gene expression unit is inserted pHLX201 carrier for expression of eukaryon by the method for enzyme action, connection, connect product transformed competence colibacillus cell, the correct carrier connected of screening is as the recombiant plasmid successfully constructed.
Preferably, described step 2) in, screening method particularly includes: adopting the 2YT culture medium being added with Amp to select to cultivate the competent cell having converted connection product, picking monoclonal carries out bacterium colony PCR, to PCR primer electrophoretic analysis or sequencing analysis.
Preferably, described step 2) in, screening method particularly includes: after recombinant plasmid transformed Chinese hamster ovary celI, carry out pressurization screening by MSX, it is thus achieved that the cell strain of stably express.
Preferably, final concentration of 20~60 μm of ol of described MSX pressurization screening.
Fifth aspect present invention provides described pHLX201 carrier for expression of eukaryon, pHLX201-CHO eukaryotic expression system purposes in expression of recombinant proteins.
The invention discloses a kind of gene expression system utilizing the dual-gene carrier for expression of eukaryon of pHLX201 to produce recombiant protein in Chinese hamster ovary celI, this expression system is capable of exogenous gene integration in Chinese hamster ovary celI genome and high efficient expression.The preparation method of this system specifically includes that structure carrier for expression of eukaryon, is suitable for genes of interest transient expression in Chinese hamster ovary celI, and is suitable for the screening of genes of interest overexpression cell line.The CHO expression system utilizing the present invention can realize the integration in Chinese hamster ovary celI such as recombiant protein, monoclonal antibody and expression, has broad application prospects.
Accompanying drawing explanation
Fig. 1: pcr amplified fragment " promoter A+HLX01-LC+SV40polyA " and linearisation pHLX101-HLX01-HC electrophoretogram (L1-L4: with primer S322, S323 amplification of DNA fragments " promoter A+HLX01-LC+SV40polyA ", L5-L8: with primer S324, S325 linearized vector pHLX101-HLX01-HCPCR product)
Fig. 2: bacterium solution PCR identifies positive monoclonal electrophoretogram (M:DNAMaker, L1-L7: with the product of primer S138 and primer S146 amplification, size is about 4200 base pairs, L8: the PCR primer being template with pHLX101-HLX01-HC carrier)
Fig. 3: GS gene leading portion and back segment PCR primer electrophoretogram (L1: with primer S341 and the primer S350 PCR primer to GS gene leading portion, L2: by primer S342 and the primer S3549 PCR primer to GS gene back segment)
Fig. 4: TK promoter and GS gene fusion electrophoretogram (M:DNAMarker, L1-L2:TK and GS merge afterproduct, L3: reclaim TK and GS in glue and merge afterproduct)
Fig. 5: bacterium solution PCR identifies positive monoclonal electrophoretogram (M:DNAMarker, L1-L10:1-10 monoclonal bacterium solution is the PCR primer of template)
Fig. 6: SV40L promoter and GS leading portion PCR primer electrophoretogram (M:DNAMarker, L1:SV40L promoter and GS leading portion PCR primer)
Fig. 7: SV40L promoter and GS merge electrophoretogram (M:DNAMarker, L1:SV40L promoter and GS leading portion, back segment fusion product, be sized to 4964 base pairs)
Fig. 8: pHLX101-HLX01 double gene expression vector XhoI and NotI double digestion collection of illustrative plates
Fig. 9: plasmid double digestion screening positive clone electrophoretogram (M:DNAMarker, L1:4# clone is little takes out plasmid, L3:4# cloned plasmids double digestion XhoI and NotI, L2:8# clone is little takes out plasmid, L4:8# clone is little takes out plasmid double digestion XhoI and NotI, the little plasmid of taking out of L5:13#, L6:13# clone is little takes out plasmid double digestion XhoI and NotI)
Figure 10: pHLX201-HLX01 double gene expression vector increases I-SceI recognition site PCR electrophoretogram (M:DNAMarker, L1: primer S364, S365 amplified production, SacII → I-SceI fragment, it is sized to 2262 base pairs, L2: primer S366, S367 amplified production, I-SceI → HindIII fragment, is sized to 1192 base pairs)
SacII → I-SceI fragment and I-SceI → HindIII segment composition electrophoretogram (M:DNAMarker in Figure 11: Figure 11, L1:SacII → I-SceI fragment and I-SceI → HindIII segment composition afterproduct, L2: fusion product primer S364, S367 expands afterproduct, size is about 3300 base pairs, L3: reclaim fusion product in glue)
Figure 12: pHLX201-HLX01 double gene expression vector restriction enzyme digestion and electrophoresis figure (M:DNAMarker, L1:pHLX201-HLX01 is little takes out plasmid, result after plasmid SacII and HindIII enzyme action in L2:L1, reclaims gel electrophoresis result after plasmid SacII and HindIII enzyme action in L3:L1)
Positive colony the selection result (after M:DNAMarker, L1-11:1-11# cloned plasmids SacII, I-SceI and HindIII enzyme action result) behind Figure 13: pHLX201-HLX01 double gene expression vector increase I-SceI site
Figure 14: pHLX201-HLX01 and pEE14.4-HLX01 double gene expression vector electricity turns linearized prior electrophoretogram (M:DNAMarker, L1:pEE14.4-HLX01 double gene expression vector, in take out plasmid, L2:PvuI digests pEE14.4-HLX01 double gene expression vector, taking out plasmid in L3:pHLX201-HLX01I-SceI, L4:I-SceI digests pHLX201-HLX01 plasmid)
Figure 15: pHLX101 double gene expression vector collection of illustrative plates
Figure 16: pHLX101TKGS double gene expression vector collection of illustrative plates
Figure 17: pHLX201 double gene expression vector collection of illustrative plates
Figure 18: annular pHLX101, pHLX201 and pEE14.4 double gene expression vector ability to express in CHO-S cell compares
Figure 19: linearizing pHLX201 and pEE14.4 double gene expression vector ability to express compares
Detailed description of the invention
Below by way of specific instantiation, embodiments of the present invention being described, those skilled in the art the content disclosed by this specification can understand other advantages and effect of the present invention easily.The present invention can also be carried out by additionally different detailed description of the invention or apply, and the every details in this specification based on different viewpoints and application, can also carry out various modification or change under the spirit without departing from the present invention.
Before further describing the specific embodiment of the invention, it should be appreciated that protection scope of the present invention is not limited to following specific specific embodiments;It is also understood that the term used in the embodiment of the present invention is to describe specific specific embodiments, rather than in order to limit the scope of the invention;In specification and claims of the present invention, unless additionally explicitly pointed out in literary composition, singulative " ", " one " and " this " include plural form.
When embodiment provides numerical range, it should be appreciated that unless the present invention is otherwise noted, between two end points and two end points of each numerical range, any one numerical value all can be selected for.Unless otherwise defined, the same meaning that all technology used in the present invention and scientific terminology and those skilled in the art of the present technique are generally understood that.Except the concrete grammar used in embodiment, equipment, material, record according to those skilled in the art's grasp to prior art and the present invention, it is also possible to use similar with the method described in the embodiment of the present invention, equipment, material or that be equal to any method of prior art, equipment and material to realize the present invention.
Unless otherwise indicated, the experimental technique that disclosed in this invention, detection method, preparation method all adopt the conventional molecular biology of the art, biochemistry, chromatin Structure and analysis, analytical chemistry, cell are cultivated, the routine techniques of recombinant DNA technology and association area.These technology existing improving in existing document illustrates, specifically can referring to the MOLECULARCLONING:ALABORATORYMANUAL such as Sambrook, Secondedition, ColdSpringHarborLaboratoryPress, 1989andThirdedition, 2001;Ausubel etc., CURRENTPROTOCOLSINMOLECULARBIOLOGY, john wiley & sons, NewYork, 1987andperiodicupdates;TheseriesMETHODSINENZYMOLOGY, AcademicPress, SanDiego;Wolffe, CHROMATINSTRUCTUREANDFUNCTION, Thirdedition, AcademicPress, SanDiego, 1998;METHODSINENZYMOLOGY, Vol.304, Chromatin (P.M.WassarmanandA.P.Wolffe, eds.), AcademicPress, SanDiego, 1999;And METHODSINMOLECULARBIOLOGY, Vol.119, ChromatinProtocols (P.B.Becker, ed.) HumanaPress, Totowa, 1999 etc..
Embodiment 1
The structure of pHLX101 double gene expression vector
Use primer S322, pHLX101-HLX01-HC (is built by S323 by Shanghai Henlius Biotech Co. Ltd., referring to Chinese patent 201210211812.1) expression vector linearisation, framework as double gene expression vector, use primer S324 again, S325 expands pHLX101-HLX01-LC and (is built by Shanghai Henlius Biotech Co. Ltd., referring to Chinese patent 201210211812.1) transcriptional units of expression vector, including promoter A sequence, HLX01 light chain gene sequence and SV40polyA gene order, it is simultaneously introduced restriction enzyme site BglII and XhoI.
Table 1.PCR primer sequence table
Linearisation pHLX101-HLX01-HCPCR reaction condition: degeneration 98 DEG C 10 seconds, anneal 58 DEG C 5 seconds, extend 72 DEG C 120 seconds, 35 circulations.
The transcriptional units reaction condition of amplification pHLX101-HLX01-LC expression vector: degeneration 98 DEG C 10 seconds, anneal 58 DEG C 5 seconds, extend 72 DEG C 60 seconds, 35 circulate.
Agarose gel electrophoresis result is as shown in Figure 1, the light chain expression unit of amplification and linearized vector are carried out glue and reclaims purification, then digest 1 hour in 37 DEG C of water-baths with restriction endonuclease BglII and XhoI respectively, reaction terminate after purifying DNA fragment and carrier again, light chain expression unit is attached reaction with carrier under ligase (NEB Products) acts on, connection product is converted and enters bacillus coli DH 5 alpha competent cell.
Positive monoclonal qualification is carried out with PCR reaction, the primer is S138 (SEQIDNO:10) and S146 (SEQIDNO:11), PCR reaction condition is: degeneration 98 DEG C 10 seconds, anneal 58 DEG C 5 seconds, extend 72 DEG C 60 seconds, 35 circulations, as in figure 2 it is shown, correct carrier called after pHLX101Dual-HLX01 will be identified.
Embodiment 2
Optimize GS and express unit sequence
1. build the pHLX101 double gene expression vector containing TK promoter and Chinese hamster ovary celI GS gene
1.1GS gene order synthesis chemical synthesis prepares leading portion and the back segment of GS gene, and wherein leading portion sequence is the 1-1691 of SEQIDNo.3, and back segment is the 1686-4599 of SEQIDNo.3.Adopt primer S341 (SEQIDNo.12) and S350 (SEQIDNo.13) and S342 (SEQIDNo.14) and S349 (SEQIDNo.15), PCR is utilized to expand leading portion and the back segment of GS gene respectively, PCR reaction condition: degeneration 98 DEG C 5 seconds, anneal 58 DEG C 5 seconds, extend 72 DEG C 60 seconds, 35 circulations.
1.2TK promoter sequence synthesis primer S355 (SEQIDNo.16) and S337 (SEQIDNo.18), with carrier pHLX101 for template, amplifies TK promoter.PCR reaction condition: degeneration 98 DEG C 5 seconds, anneal 58 DEG C 5 seconds, extend 72 DEG C 10 seconds, 25 circulations.
1.3 merge TK promoter, GS gene leading portion and back segment
Table 2. fusion reaction system
Reaction condition: degeneration 98 DEG C 10 seconds, anneal 58 DEG C 5 seconds, extend 72 DEG C 3 minutes, 25 circulations.After fusion, DNA fragmentation carries out agarose gel analysis, as it is shown on figure 3, then the fragment being sized to 4770 base pairs reclaimed.
1.4 merge fragment (including TK promoter, GS gene leading portion and back segment) XhoI and NotI with restriction endonuclease XhoI and NotI digestion digests 1 hour in 37 DEG C of water-baths fusion fragment simultaneously, carrier pHLX101Dual-HLX01 also digests with XhoI and NotI simultaneously, through agarose gel electrophoresis, and reclaim the carrier segments being sized to 7200 base pairs, as shown in Figure 4.
Fusion fragment after endonuclease digestion purification and carrier are attached by 1.5 coupled reaction quick ligase, select monoclonal to cultivate in 2YT culture medium, PCR reaction is done for template with bacterium solution, result is as shown in Figure 5, positive colony is sent to go sequence verification, by carrier called after pHLX101DualTKGS-HLX01 correct for order-checking.
2. build the pHLX101 double gene expression vector containing SV40L promoter and Chinese hamster ovary celI source GS and pHLX201 double gene expression vector
2.1 amplification Chinese hamster ovary celI source GS leading portion and promoter SV40L thereof: the warm fragment (SEQIDNo.17) of SV40L and GS leading portion sequence is prepared in chemosynthesis, with this sequence be template primer S350 (SEQIDNo.13), S360 (SEQIDNo.19) amplification obtain SV40L and GS leading portion sequence, reaction condition: degeneration 98 DEG C 10 seconds, anneal 58 DEG C 5 seconds, extend 72 DEG C 1 minute, 30 circulations.Result as shown in Figure 6, then merges with the GS back segment for preparing in embodiment 1.1, and fusion reaction is: degeneration 98 DEG C 10 seconds, anneal 58 DEG C 5 seconds, extend 72 DEG C 2 minutes, 20 circulate.Merging successful fragment electrophoresis in agarose gel, result is as it is shown in fig. 7, after separating with non-purpose band, rubber tapping is reclaimed.
2.2 enzyme action coupled reactions: simultaneously digest fusion fragment SV40L and GS complete sequence that embodiment 2.1 prepares with NotI and XhoI, with the two enzyme, the pHLX101Dual-HLX01 double gene expression vector obtained in embodiment 1.4 is carried out digestion reaction equally, purpose fragment is rubber tapping recovery after electrophoresis in agarose gel, and result is Fig. 8 such as.Take the carrier after 30ng enzyme action and SV40L and GS after 70ng enzyme action merges fragment, be attached reaction with quick ligase, connect product and be transformed into DH5 α competent cell.Extracting the plasmid of positive colony, through NotI and XhoI digestion verification screening positive clone, result is Fig. 9 such as.
2.3 add linearisation restriction enzyme site owing to changing GS and promoter sequence thereof in pHLX101 double gene expression vector, original vector linearization restriction enzyme site can not be continuing with, so needing under not affecting each element function premise, carrier increases a new restriction enzyme enzyme recognition site.
I-SceI recognition sequence is: TAGGGATAACAGGGTAAT (5 ' → 3 '), and sequence is longer, is not easily repeated, and endonuclease reaction easily carries out.In order to introduce I-SceI recognition site at pHLX201 1061-1062 base place, design primer S364 (SEQIDNo.20) and S365 (SEQIDNo.21) and S366 (SEQIDNo.22) and S367 (SEQIDNo.23), the plasmid obtained with embodiment 2.2 is for template, adopt PCR reaction, reaction condition is: degeneration 98 DEG C 10 seconds, anneal 58 DEG C 5 seconds, extend 72 DEG C 1 minute, 35 circulation.Amplifying the DNA fragmentation product being sized to 2262 base pairs and 1192 base pairs respectively, amplified production is through agarose gel electrophoresis separating resulting as shown in Figure 10.Utilizing PCR fusion reaction to be merged by two segment DNAs, using primer, to be S364 and S367 fusion reaction condition is: degeneration 98 DEG C 10 seconds, anneal 58 DEG C 5 seconds, extend 72 DEG C 2 minutes, 20 circulate.Fusion product electrophoresis reclaiming in agarose gel, result is Figure 11 such as.
Respectively the pHLX201 double gene expression vector of preparation in above-mentioned fusion fragment and embodiment 2.2 is digested with SacII and HindIII, sheet segment DNA purification kit is purified after terminating by reaction, electrophoresis is condensed through agarose to pHLX201 is dual-gene, result is Figure 12 such as, then carries out rubber tapping and reclaims.Mix with fragment, carrier with quick ligase again, react 5 minutes in 25 DEG C of water-baths, connect product and convert entrance DH5 α competent cell.With digestion verification screening positive clone comparing result such as Figure 13.
3. the pHLX101 in comparative example 1.4 and pHLX201 double gene expression vector expression in CHO-S cell in example 2.3
3.1 electricity turn: by pHLX101DualTKGS-HLX01, pHLX201-HLX01 and pEE14.4-HLX01 double gene expression plasmid electricity rotates into into GS (glutamine synthetase gene) the CHO-S cell knocked out, after 48 hours, electricity is turned rear cell and carries out activity counts, with 5000 cells/well, the density of 10000 cells/well is bed board in 96 orifice plates, the concentration of selective agent MSX respectively 0 μM under each density, 20 μMs, 40 μMs, 60 μMs, the culture medium of Select to use is the CDCHO containing 1 × GSSupplement and finite concentration MSX.
3.2 screenings: electricity turns after rear cell kind enters 96 orifice plates puts into 37 DEG C, 5%CO2Incubator in, monoclonal growth needs 18 to 22 days.From table 3 it is observed that pHLX101DualTKGS-HLX01 grows almost without clone, and pHLX201-HLX01 and pEE14.4-HLX01 has a number of clone to grow, and the plasmid with TK promoter is described, it is impossible to express effective GS gene.And pHLX201-HLX01 is capable of withstanding the screening by finite concentration MSX, illustrate that the promoter of SV40L is better than TK promoter under this condition.
In 3.396 orifice plates, IgG expression is quantitative: be coated 96 half-pore plate with the 2 anti-human Fd multi-resistance of μ g/mL, and PBS rinses 2 times, then closes 96 half-pore plate 1 hour with the PBS containing 5% milk, and PBS rinses 2 times;Taking supernatant 10uL in the hole that clonal growth goes out, dilute 200 or 400 times with PBS, in half-pore plate, every hole adds 30uL, and room temperature was in conjunction with 1 hour;Being sucked by supernatant, PBS rinses 3 times;In every hole add the anti-human kappa light chain of 30uL and with HRP labelling two resist, room temperature was in conjunction with 1 hour;Being sucked by supernatant, PBS rinses 4 times.Every hole adds 30uLTMB, reacts 3 to 5 minutes with 2MH2SO4Terminate reaction, under 450nm wavelength, finally read light absorption value.Result is Figure 18 such as, it can be seen that the expression of the clone of pHLX201-HLX01, and what wherein expression was high can reach 50 μ g/mL, close with the expression of business-like expression vector pEE14.4-HLX01.
The each screening conditions of table 3. place an order colony counts statistics
4. compare plasmid and pEE14.4-HLX01 expression in CHO-S cell in linearisation example 2.3
4.1 linearization plasmids: entering host cell gene group efficiency for improving plasmid integration, digest, with restricted enzyme I-SceI, the plasmid that example 2.3 obtains, restricted enzyme PvuI digests pEE14.4-HLX01, identifies through agarose gel electrophoresis, and result is Figure 14 such as.
4.2 purification also concentrate plasmid: fully mix with equal-volume phenol/chloroform/isoamyl alcohol (25:24:1) and plasmid solution, upper strata aqueous phase is taken to another new pipe after high speed centrifugation, fully mix with the aqueous phase containing DNA with equal-volume chloroform, high speed centrifugation Hou Qu the superiors aqueous phase is to another new pipe, add the 3MNaAC of 1/10 volume, pH5.2, plasmid DNA is made to precipitate after adding the dehydrated alcohol mixing of 3 times of volumes, 14000 revs/min are centrifuged 10 minutes, DNA is made to be precipitated at the bottom of pipe, abandon supernatant, precipitate 2 times with 75% washing with alcohol DNA of pre-cooling, DNA is made to precipitate at room temperature natural drying, the ultra-pure water adding certain volume makes DNA dissolve, and concentration is not less than 1ug/uL.
4.3 electricity turn: rotate into into GS (glutamine synthetase gene) the CHO-S cell knocked out by linearizing pHLX201-HLX01 and pEE14.4-HLX01 double gene expression plasmid electricity, after 48 hours, electricity is turned rear cell and carries out activity counts, with 3000 cells/well, the density of 6000 cells/well and 9000 cells/well is bed board in 96 orifice plates, the concentration of selective agent MSX respectively 0 μM under each density, 20 μMs, 40 μMs, 60 μMs, the culture medium of Select to use is the CDCHO containing 1 × GSSupplement and finite concentration MSX.
4.4 screenings: electricity turns after rear cell kind enters 96 orifice plates puts into 37 DEG C, 5%CO2Incubator in, monoclonal growth needs 18 to 22 days.
In 4.596 orifice plates, IgG expression is quantitative: be coated 96 half-pore plate with the 2 anti-human Fd multi-resistance of μ g/mL, and PBS rinses 2 times, then closes 96 half-pore plate 1 hour with the PBS containing 5% milk, and PBS rinses 2 times;Taking supernatant 10uL in the hole that clonal growth goes out, dilute 200 or 400 times with PBS, in half-pore plate, every hole adds 30uL, and room temperature was in conjunction with 1 hour;Being sucked by supernatant, PBS rinses 3 times;In every hole add the anti-human kappa light chain of 30uL and with HRP labelling two resist, room temperature was in conjunction with 1 hour;Being sucked by supernatant, PBS rinses 4 times.Every hole adds 30uLTMB, reacts 3 to 5 minutes with 2MH2SO4Terminate reaction, under 450nm wavelength, finally read light absorption value.
4.6 compare expression in tubular reactor: cell sucking-off the highest for expression in 96 orifice plates put in 24 orifice plates and cultivate 3 to 4 days, and total cellular score increases to 106During individual left and right, cell is transferred in 5mL tubular reactor, carries out amplification cultivation, the cell density of all clones is adjusted to 3 × 105Individual/mL, starts to do feed-batch culture.During cultivation, Cell viability and density are recorded.Treat that Cell viability drops to less than 50% collection culture supernatant, do quantitatively with ELISA, concrete grammar and identical described in 4.5.Result is Figure 19 such as, it can be seen that the expression of pHLX201 carrier can reach 200 μ about g/mL, suitable with the expression of business-like pEE4.4.
In sum, the present invention effectively overcomes various shortcoming of the prior art and has high industrial utilization.
Above-described embodiment is illustrative principles of the invention and effect thereof only, not for the restriction present invention.Above-described embodiment all under the spirit and category of the present invention, can be modified or change by any those skilled in the art.Therefore, art has usually intellectual such as modifying without departing from all equivalences completed under disclosed spirit and technological thought or change, must be contained by the claim of the present invention.
Claims (12)
1. a pHLX201 carrier for expression of eukaryon, unit is expressed including GS, described GS expresses the sequence of unit and includes SV40L promoter gene sequence, the glutamine synthetase gene sequence that 5 ' to 3 ' directions are arranged in order, and described SV40L promoter gene sequence is such as shown in SEQIDNO:2;Described glutamine synthetase gene sequence is such as shown in SEQIDNO:3.
2. a kind of pHLX201 carrier for expression of eukaryon as claimed in claim 1, it is characterised in that described GS expresses unit gene order such as shown in SEQIDNO:4.
3. a kind of pHLX201 carrier for expression of eukaryon as claimed in claim 1, it is characterized in that, described GS expresses the sequence of unit and also includes restriction enzyme site sequence, and described GS expresses the sequence of unit and includes restriction enzyme site sequence, SV40L promoter gene sequence, glutamine synthetase gene sequence and the restriction enzyme site sequence that 5 ' to 3 ' directions are arranged in order.
4. a kind of pHLX201 carrier for expression of eukaryon as claimed in claim 3, it is characterised in that the described restriction enzyme site sequence one or more combination in HindIII enzyme, NotI enzyme, XhoI enzyme.
5. a kind of pHLX201 carrier for expression of eukaryon as claimed in claim 4, it is characterised in that the described GS containing restriction enzyme site expresses unit sequence such as shown in SEQIDNO:5.
6. a kind of pHLX201 carrier for expression of eukaryon as claimed in claim 1, it is characterised in that pHLX201 carrier for expression of eukaryon provided by the present invention is to be obtained by the transformation of pHLX101 carrier for expression of eukaryon.
7. the preparation method of the pHLX201 carrier for expression of eukaryon as described in claim 1-6 any claim, is obtained by the transformation of pHLX101 carrier for expression of eukaryon, and transformation process mainly comprises the steps:
By the method for PCR by pHLX101 vector linearization, and add restriction enzyme site sequence at two ends, change single-gene expression vector into double gene expression vector;Replace original GS and express unit, adopt PCR, enzyme action, connection method new GS expressed unit insert expression vector, screen, identify and correct connect the pHLX201 carrier for expression of eukaryon that product is the present invention.
8. preparation method as claimed in claim 7, it is characterised in that specifically include following steps:
1) preparation of dual-gene carrier: utilize primer S322 and S323 to expand light chain of antibody and express unit, linearizing antibody heavy chain gene expression vector is obtained as the skeleton building dual-gene carrier again with primer S324, S325, two above fragment is connected, converts, screen correct transformant;
2) GS expresses the optimization of unit: with SV40L promoter composition, the glutamine synthetase gene of Chinese hamster ovary celI is expressed unit, and add restriction enzyme site at two ends simultaneously, connect insertion pHLX101 double gene expression vector respectively by enzyme action, replace original GS on carrier and express unit.
9. a pHLX201-CHO eukaryotic expression system, including the pHLX201 carrier for expression of eukaryon as described in claim 1-6 any claim and Chinese hamster ovary cell.
10. pHLX201-CHO eukaryotic expression system as claimed in claim 9, it is characterised in that described Chinese hamster ovary cell is the CHO-S cell of GS gene knockout.
11. the method that the pHLX201-CHO eukaryotic expression system as described in claim 9-10 any claim prepares recombiant protein, comprise the steps:
1) structure of recombiant plasmid: first the exogenous gene expression unit of recombiant protein 1 or recombiant protein 2 is inserted in pHLX201 single-gene expression vector respectively, the recombiant plasmid that then construction expression is dual-gene again;
2) screening of expression system: recombinant plasmid transformed Chinese hamster ovary celI, the cell strain of screening stably express is as pHLX201-CHO eukaryotic expression system;
3) the pHLX201-CHO eukaryotic expression system adopting previous step screening expresses recombiant protein.
12. the pHLX201 carrier for expression of eukaryon as described in claim 1-6 any claim, the purposes in expression of recombinant proteins of the pHLX201-CHO eukaryotic expression system as described in claim 9-10 any claim.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410853298.0A CN105802995A (en) | 2014-12-31 | 2014-12-31 | Gene expression system for producing recombinant protein by using CHO cells and eukaryotic expression vector |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410853298.0A CN105802995A (en) | 2014-12-31 | 2014-12-31 | Gene expression system for producing recombinant protein by using CHO cells and eukaryotic expression vector |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105802995A true CN105802995A (en) | 2016-07-27 |
Family
ID=56421383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410853298.0A Pending CN105802995A (en) | 2014-12-31 | 2014-12-31 | Gene expression system for producing recombinant protein by using CHO cells and eukaryotic expression vector |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105802995A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108085337A (en) * | 2017-12-28 | 2018-05-29 | 未名生物医药有限公司 | A kind of screening technique of GS expression systems cell line |
| CN109628489A (en) * | 2019-01-07 | 2019-04-16 | 新乡医学院 | A kind of method and its application improving Chinese hamster ovary celI recombinant protein expression, expression vector, expression system and preparation method thereof |
| CN119859647A (en) * | 2024-05-10 | 2025-04-22 | 重庆艾生斯生物工程有限公司 | DNA vector, method for inserting exogenous gene sequence at fixed point and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1668749A (en) * | 2002-07-18 | 2005-09-14 | 英国龙沙生物医药股份有限公司 | Method for expressing recombinant protein in CHO cells |
| WO2010041145A2 (en) * | 2008-10-07 | 2010-04-15 | Novimmune Sa | Il-17-mediated transfection methods |
| CN103509823A (en) * | 2012-06-25 | 2014-01-15 | 上海复宏汉霖生物技术有限公司 | Eukaryotic expression vector for producing recombinant protein by using CHO cells, and system |
-
2014
- 2014-12-31 CN CN201410853298.0A patent/CN105802995A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1668749A (en) * | 2002-07-18 | 2005-09-14 | 英国龙沙生物医药股份有限公司 | Method for expressing recombinant protein in CHO cells |
| WO2010041145A2 (en) * | 2008-10-07 | 2010-04-15 | Novimmune Sa | Il-17-mediated transfection methods |
| CN103509823A (en) * | 2012-06-25 | 2014-01-15 | 上海复宏汉霖生物技术有限公司 | Eukaryotic expression vector for producing recombinant protein by using CHO cells, and system |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108085337A (en) * | 2017-12-28 | 2018-05-29 | 未名生物医药有限公司 | A kind of screening technique of GS expression systems cell line |
| CN108085337B (en) * | 2017-12-28 | 2020-10-16 | 未名生物医药有限公司 | Screening method of GS expression system cell strain |
| CN109628489A (en) * | 2019-01-07 | 2019-04-16 | 新乡医学院 | A kind of method and its application improving Chinese hamster ovary celI recombinant protein expression, expression vector, expression system and preparation method thereof |
| CN109628489B (en) * | 2019-01-07 | 2022-09-23 | 新乡医学院 | Method for improving expression level of CHO cell recombinant protein and application thereof, expression vector, expression system and preparation method thereof |
| CN119859647A (en) * | 2024-05-10 | 2025-04-22 | 重庆艾生斯生物工程有限公司 | DNA vector, method for inserting exogenous gene sequence at fixed point and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105400773B (en) | CRISPR/Cas9 applied to Large-scale Screening cancer gene is enriched with sequencing approach | |
| US9434974B2 (en) | Installation of genomes or partial genomes into cells or cell-like systems | |
| CN104419701B (en) | The quick assemble method of the yeast of multiple clips DNA | |
| CN106399360A (en) | FUT8 gene knockout method based on CRISPR technology | |
| CN106244591A (en) | Modify crRNA application in CRISPR/Cpf1 gene editing system | |
| CN109880851A (en) | For being enriched with the screening report carrier and screening technique of the homologous recombination repair cell of CRISPR/Cas9 mediation | |
| CN102181471B (en) | Method for constructing secretory expression carrier and secretory expression system of Chlammydomonas reinhardtii | |
| CN121022941B (en) | A method for efficient expression of exogenous proteins based on the NC_048604-1 site in the CHO cell genome | |
| CN109486814A (en) | A kind of gRNA for repairing HBB1 point mutation, gene editing system, expression vector and gene editing kit | |
| CN105255895B (en) | MAR transcriptional regulatory elements and its expression system for the raising protein expression level of eukaryotic cell lines | |
| CN106282119B (en) | Transformation of a site-specific integration Chinese hamster ovary cell line and its use | |
| Jiang et al. | Development and optimization of CRISPR prime editing system in photoautotrophic cells | |
| CN104328138A (en) | Method and kit for directional knockout of target gene in genome target | |
| CN118048252A (en) | A saccharomyces cerevisiae engineered strain producing p-coumaryl-CoA, construction method and application thereof | |
| CN111057654A (en) | Cas9 gene knockout vector applicable to morinda officinalis endophytic fungus A761 and construction method and application thereof | |
| CN103509823B (en) | A kind of carrier for expression of eukaryon and system producing recombinant protein using Chinese hamster ovary celI | |
| CN104894255A (en) | Method for detecting low-efficiency genome editing based on polyacrylamide gel electrophoresis and application of method | |
| CN102453729B (en) | A kind of platform of fast high-flux Restruction albumen | |
| CN105622729A (en) | Polypeptides capable of realizing targeted editing of GS gene, and proteins thereof | |
| CN111019922B (en) | Mutant restriction enzyme BsaI and preparation method and application thereof | |
| CN118086353A (en) | E.coli-saccharomycete shuttle plasmid vector, recombinant plasmid and application thereof | |
| CN114921464A (en) | Artificial non-coding RNA molecule CsiX for regulating and controlling synthesis yield of carotene compounds and application thereof | |
| CN114921465B (en) | Regulatory element CsiZ and application thereof in improvement of synthetic yield of terpenoid | |
| CN105802926A (en) | Triterpene-2-alpha-hydroxylase MAA45, related biological materials thereof and application of triterpene two-bit alpha-hydroxylase MAA45 and related biological materials in preparing maslinic acid and corosolic acid | |
| CN114921463B (en) | Artificial non-coding RNA molecule CsiY for regulating and controlling synthesis yield of terpenoid and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: Room 303 and 304, Building No. 1999, Zhangheng Road, China (Shanghai) Free Trade Pilot Area, Pudong New Area, Shanghai, 201210 Applicant after: Shanghai fugrand hilink biotechnology Limited by Share Ltd Address before: Room 724, 7th floor, 780 Cailun Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai 201210 Applicant before: Shanghai Henlius Biotech Co. Ltd. |
|
| CB02 | Change of applicant information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160727 |
|
| RJ01 | Rejection of invention patent application after publication |